| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.28 | 4e-06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.25 | 6e-06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |